ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

Lombardi Recruits Adams-Campbell.

October 3, 2008

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

DRCCA Board Oks Noncompetitive Contract Concepts

November 11, 1983

Women 80 And Older Benefit From Mammography

May 30, 2008

NCI Offers Informations, Resources, To Industry.

April 6, 2001

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022